Cargando…
375. Tolerability of Anidulafungin for Candidemia in Patients With Hepatic or Renal Dysfunction
BACKGROUND: Anidulafungin has been prescribed in patients with candidemia, especially hepatic or renal dysfunction because of not undergoing metabolism in the liver and kidney. The purpose of this study was to evaluate the safety of anidulafungin in these patient populations. METHODS: We retrospecti...
Autores principales: | Kim, Ji Young, Jung, Dong Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254033/ http://dx.doi.org/10.1093/ofid/ofy210.386 |
Ejemplares similares
-
817. Caspofungin versus Anidulafungin in Patients with Candidemia: Retrospective Comparative Study
por: Elajez, Reem, et al.
Publicado: (2023) -
Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
por: Suh, Jin Woong, et al.
Publicado: (2020) -
2111. Anidulafungin vs. Micafungin Treatment in Adult Patients with Candidemia: A Retrospective Study of Single-Center Experience
por: Suh, Jinwoong, et al.
Publicado: (2019) -
Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011) -
Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
por: Roilides, Emmanuel, et al.
Publicado: (2020)